NCT01805388

Brief Summary

The purpose of our study is to characterize the composition of the hard and soft tissues present after regenerative endodontic procedures in root canals of teeth previously diagnosed with the need for extraction for orthodontic treatment and incomplete root formation. Although the protocol addressed in this study is currently being used in clinical practice, there are no prospective clinical trials investigating its efficacy in stimulating continued root development and the nature of the newly formed tissues.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2013

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

February 28, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

February 5, 2016

Status Verified

February 1, 2016

Enrollment Period

2.7 years

First QC Date

February 28, 2013

Last Update Submit

February 4, 2016

Conditions

Keywords

Dental Pulp Regeneration

Outcome Measures

Primary Outcomes (1)

  • Histological identification of the mineralized tissue at the apical third of the root and the adherent cellular layer.

    Although we predict histological identification of dentin/odontoblasts (due to the proximity of the apical papilla and associated SCAP stem cells) using our scanning laser confocal microscopy system, our methods are sufficiently sensitive to permit identification of bone/osteoblasts and cementum/cementoblasts as alternative hypotheses.

    Following tooth extraction at the 3 month followup visit. Correlation of all data collected from the extracted teeth will occur at the completion of the study at year 5.

Secondary Outcomes (1)

  • Whether stem cells enter the canal space when bleeding is stimulated through manipulation of the apical papilla.

    Canal bleeding is evoked during the second treatment visit thirty days following the first treatment. Blood collected by paper points will be saved till the end of the study (year 5) for analysis.

Study Arms (2)

Regeneration Treatment Group

EXPERIMENTAL

RTC with Triple Antibiotic Study Drug

Drug: Experimental: Regeneration Treatment GroupProcedure: Control Non-Study Drug Group

Control Non-study Drug Group

NO INTERVENTION

RTC on contralateral tooth with no study drug

Interventions

Regenerative Root Canal Therapy using Triple Antibiotic Paste study drug

Also known as: Regenerative RTC using Triple Antibiotic Paste study drug
Regeneration Treatment Group

Endodontic RTC with no study drug

Also known as: Root Canal Therapy
Regeneration Treatment Group

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children ages 9-18 with bilateral premolars with incomplete root development scheduled for extraction for orthodontic reasons.
  • Children who seem to be cooperative with dental treatment and able to indicate willingness to obtain treatment and participate in the study and who are capable of verbally expressing dissent.
  • Parents who express understanding of study treatments and consent to treatment for their child of the regenerative procedure prior to the tooth extraction for orthodontic reasons .
  • Healthy patients (ASA Class I or II physical status) with no systemic health problems that may interfere with healing and cell growth.
  • Permanent premolar teeth with immature root development and healthy pulps scheduled for extraction due to orthodontic requirements.
  • Clinically confirmed teeth with good periodontal health assessed by periodontal probing depths of less than 4mm.

You may not qualify if:

  • Parents and patients unable to give consent or express dissent.
  • Patients who are unwilling to undergo the research and orthodontic dental treatment.
  • Patients affected by tempromandibular joint disorders.
  • Patients affected by known orofacial pain disorders.
  • Patients with ASA Class III or IV physical status (Immuno-compromised patients including patients who self-report that they are an HIV carrier, undergoing steroid therapy or chemotherapy, or those who self-report with genetic or systemic diseases that could result in reduced immune response).
  • Teeth with vertical cracks that extend below the cemento-enamel junction.
  • Teeth that cannot be isolated using a rubber dam.
  • Teeth with non-odontogenic pathology.
  • Teeth whose apices are fully developed, as determined radiographically and correlated with dental age of patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Health Science Center

San Antonio, Texas, 78229, United States

Location

Related Publications (1)

  • Thibodeau B. Case report: pulp revascularization of a necrotic, infected, immature, permanent tooth. Pediatr Dent. 2009 Mar-Apr;31(2):145-8.

    PMID: 19455934BACKGROUND

MeSH Terms

Interventions

Root Canal Therapy

Intervention Hierarchy (Ancestors)

EndodonticsDentistry

Study Officials

  • Anibal R Diogenes, DDS, PhD

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR
  • Dubravko Pavlin, DMD, PhD

    University of Texas Health Science Center San Antonio

    PRINCIPAL INVESTIGATOR
  • Kenneth M Hargreaves, DDS, PhD

    University of Texas Health Science Center San Antonio

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

February 28, 2013

First Posted

March 6, 2013

Study Start

February 1, 2013

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

February 5, 2016

Record last verified: 2016-02

Locations